PAK1 and lymphoma: In lymphoma, gene expression profiling in the drugs treated with BKM120, BEZ235, and BGT226 (PI3K and PI3K/MTOR inhibitors) in a panel of 60 cells showed higher expression of PAK1 association with PI3K resistance.